Bone demineralization and impaired mineral metabolism in insulin-dependent diabetes mellitus. A possible role of magnesium deficiency
- PMID: 2787312
Bone demineralization and impaired mineral metabolism in insulin-dependent diabetes mellitus. A possible role of magnesium deficiency
Abstract
Osteoporosis, a recognized complication of insulin-dependent diabetes mellitus (IDDM), may be related to this complex metabolic disorder; moreover, some data emphasize an altered vitamin D metabolism or parathyroid hormone secretion. Mineral homeostasis was studied in 29 children with IDDM (18 males, 11 females; 2.6-18.0 years). In 17 patients a stimulatory test (low-calcium diet) was performed for PTH and 1.25(OH)2D. Bone mineral content (BMC) and BMC/BW were lower in respect to our normal values; bone mineral loss was directly related to HbA1c levels and insulin requirements. A significant decrease of ionized calcium (p less than 0.001) and magnesium (p less than 0.001) was found; intact PTH values were in the low normal range but decreased for the ionized calcium values. 1.25(OH)2D levels were not significantly different from normal levels. 1.25(OH)2D and intact PTH did not rise during stimulatory test. The lack of 1.25(OH)2D and intact PTH increase after the stimulatory test may be due to the parathyroid gland's hyporesponsiveness related to hypomagnesemia which impaired PTH release and/or PTH action. Our data confirm an involvement of 1.25(OH)2D and PTH regulation in diabetic osteoporosis.
Similar articles
-
Bone mineral metabolism in human type 1 (insulin dependent) diabetes mellitus.Dan Med Bull. 1988 Apr;35(2):109-21. Dan Med Bull. 1988. PMID: 3282809 Review.
-
Vitamin D physiology.Prog Biophys Mol Biol. 2006 Sep;92(1):4-8. doi: 10.1016/j.pbiomolbio.2006.02.016. Epub 2006 Feb 28. Prog Biophys Mol Biol. 2006. PMID: 16563471 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Magnesium deficiency: effect on bone and mineral metabolism in the mouse.Calcif Tissue Int. 2003 Jan;72(1):32-41. doi: 10.1007/s00223-001-1091-1. Epub 2002 Oct 10. Calcif Tissue Int. 2003. PMID: 12370796
-
Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.Rheum Dis Clin North Am. 1994 Aug;20(3):759-75. Rheum Dis Clin North Am. 1994. PMID: 7984788 Review.
Cited by
-
Metabolic control and bone health in adolescents with type 1 diabetes.Int J Pediatr Endocrinol. 2011 Oct 26;2011(1):13. doi: 10.1186/1687-9856-2011-13. Int J Pediatr Endocrinol. 2011. PMID: 22029838 Free PMC article.
-
Vitamin D status and viral response to therapy in hepatitis C infected children.World J Gastroenterol. 2015 Jan 28;21(4):1284-91. doi: 10.3748/wjg.v21.i4.1284. World J Gastroenterol. 2015. PMID: 25632203 Free PMC article. Clinical Trial.
-
Mineral accretion in growing bones--a framework for the future?Arch Dis Child. 1995 Feb;72(2):177-9. doi: 10.1136/adc.72.2.177. Arch Dis Child. 1995. PMID: 7702389 Free PMC article. Review. No abstract available.
-
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus.Biol Trace Elem Res. 1996 Jan;51(1):13-21. doi: 10.1007/BF02790143. Biol Trace Elem Res. 1996. PMID: 8834376
-
Bone mineral density in the femur and lumbar vertebrae decreases after twelve weeks of diabetes in spontaneously diabetic-prone BB/Worcester rats.Calcif Tissue Int. 1994 Mar;54(3):237-40. doi: 10.1007/BF00301685. Calcif Tissue Int. 1994. PMID: 8055373
MeSH terms
Substances
LinkOut - more resources
Medical